The Future Perspective of Combination of Artificial Intelligence, Oncolytic Virotherapy, and Immunotherapy Against Gastric Cancer

Document Type : Letter to Editor

Author

1. Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. & Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

10.32598/ARI.81.2.3695

Abstract

Gastric cancer (GC) is one of the leading causes of cancer deaths worldwide, especially in East Asia. Despite recent advances in diagnosis and therapy, the prognosis for advanced GC is poor due to late diagnosis, tumor heterogeneity, and immune evasion mechanisms. Therefore, there is an urgent need for innovative and synergistic approaches to improve treatment outcomes. The integration of artificial intelligence (AI), oncolytic virotherapy (OV), and immunotherapy has transformative potential in this context.

Keywords

Archives of Razi Institute
Volume 81, Issue 2
March and April 2026
Pages 271-272

Files

Share

How to cite

Statistics